CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/14707745

Download in:

View as

General Info

PMID
14707745